Half Year 2020 Aurobindo Pharma Ltd Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Q2 FY '20 Earnings Conference Call of Aurobindo Pharma Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Krishna Kiran, Investor Relations. Thank you, and over to you, sir.
Thank you, Margaret. Good morning, and a warm welcome to our second quarter FY '20 earnings call. I'm Krishna Kiran from the Aurobindo Pharma Investor Relations. We hope you have received the Q2 financials and the press release that we have sent out yesterday. These are also available on our website.
With me, we have our senior management team represented by Mr. P.V. Ram Prasad Reddy, Executive Chairman, Aurobindo Pharma USA; N. Govindarajan, Managing Director; Mr. Sanjeev Dani, COO, Head Formulations; Mr. Santhanam Subramanian, CFO; and Mr. Swami Iyer, CFO, Aurobindo Pharma USA.
We will begin the call with summary highlights from the management followed by an interactive Q&A session.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
